Is Allarity Therapeutics Inc (ALLR) overvalued? · P/E 0.0, $15.1M cap
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
This page asks whether Allarity Therapeutics Inc (ALLR) looks expensive on cached numbers — not a short thesis.
No cached income statement for ALLR, so there is no earnings base to call rich or cheap.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ALLR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ALLR stock page for the full model, not this heading.
Not investment advice.